...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
【24h】

A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.

机译:一例肥大细胞负担,单克隆骨髓细胞和C-KIT突变Asp-816-Val的“冒烟”肥大细胞增多症。

获取原文
获取原文并翻译 | 示例

摘要

Mastocytosis is a term used for a group of disorders characterized by abnormal growth and accumulation of tissue mast cells (MC) in one or more organ systems. In patients with systemic mastocytosis (SM) the clinical course may be indolent or aggressive or even complicated by leukemic progression or an associated clonal hematologic non mast cell lineage disease (AHNMD). However, at first presentation (diagnosis) it may be difficult to define the category of disease and the prognosis. We report on a 48-year-old female patient with SM with urticaria pigmentosa-like skin lesions and mediator-related symptoms. She was found to have splenomegaly, a high infiltration grade (MC) in bone marrow biopsies (>30%), mild anemia, and a high serum tryptase level (>500 ng/ml). In addition, she exhibited discrete histologic signs of myeloproliferation in the 'non-affected' marrow and monoclonal blood cells established by C-KIT 2468A-->T mutation (Asp-816-Val) -analysis and HUMARA assay. Despite these findings, however, the clinical course was stable over years and no AHNMD or organ impairment developed. Because of the 'intermediate' clinical signs and absence of progression to aggressive disease, we proposed the term 'smouldering mastocytosis'.
机译:肥大细胞增多症是用于一组以一个或多个器官系统中组织肥大细胞(MC)的异常生长和积累为特征的疾病的术语。在患有全身性肥大细胞增多症(SM)的患者中,临床过程可能是缓慢的或侵袭性的,甚至可能因白血病进展或相关的克隆性血液学非肥大细胞谱系疾病(AHNMD)而复杂化。但是,在首次出现(诊断)时,可能难以定义疾病的类别和预后。我们报道了一名48岁女性SM色素性荨麻疹样皮肤病和与介质相关的症状的女性患者。她被发现患有脾肿大,骨髓活检的浸润等级(MC)高(> 30%),轻度贫血和血清类胰蛋白酶水平高(> 500 ng / ml)。此外,她在通过C-KIT 2468A→T突变(Asp-816-Val)分析和HUMARA分析建立的“未受影响”骨髓和单克隆血细胞中表现出离散的骨髓增殖组织学征象。尽管有这些发现,但是,临床过程多年来稳定,并且未发生AHNMD或器官损害。由于临床症状“中等”,并且没有进展为侵袭性疾病,因此我们提出了“成脂性肥大细胞增多症”一词。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号